Top

International Urology and Nephrology

Published in:

28-07-2023 | Transurethral Prostate Resection | Urology - Original Paper

Combination of 180-W GreenLight XPS laser and bipolar transurethral resection of prostate for the treatment of large prostates beyond 100 ml: a novel hybrid technique

Authors: Mu-Yao Tsai, Chien-Hsu Chen, Po-Hui Chiang, Ping-Chia Chiang

Published in: International Urology and Nephrology | Issue 11/2023

Abstract

Background and objectives

The aim of this study was to evaluate the safety and efficacy of the 180-W GreenLight laser (GL) XPS™ plus bipolar transurethral resection of the prostate (TURP) for the treatment of a prostate volume (PV) beyond 100 ml.

Study design/materials and methods

From January 2014 to December 2022, 79 patients with PV > 100 ml who underwent GL-XPS plus bipolar TURP were enrolled. The median follow-up time was 13.7 months. The International Prostate Symptom Score (IPSS), PV, uroflow study, post-void residual (PVR) volume, and prostate-specific antigen (PSA) before and after the operation were recorded. Subgroup analysis was performed to compare the outcomes between the patients with follow-up times of < 36 months and > 36 months.

Results

Statistically significant improvements in all the postoperative parameters were observed in both < 36 months and > 36 months groups. There was no blood transfusion or transurethral resection (TUR) syndrome in this series. Most of all, a second TURP was unnecessary during the follow-up. Only one (1.3%) Clavien–Dindo grade 3b complication was noted.

Conclusions

The hybrid technique of 180-W XPS™ GreenLight laser plus bipolar TURP can be safely and efficiently performed on patients with a prostate volume of > 100 ml.

Rassweiler J et al (2006) Complications of transurethral resection of the prostate (TURP)–incidence, management, and prevention. Eur Urol 50(5):969–979 (Discussion 980)CrossRefPubMed

Chen S et al (2014) Plasmakinetic enucleation of the prostate compared with open prostatectomy for prostates larger than 100 grams: a randomized noninferiority controlled trial with long-term results at 6 years. Eur Urol 66(2):284–291CrossRefPubMed

Varkarakis I et al (2004) Long-term results of open transvesical prostatectomy from a contemporary series of patients. Urology 64(2):306–310CrossRefPubMed

Gratzke C et al (2007) Complications and early postoperative outcome after open prostatectomy in patients with benign prostatic enlargement: results of a prospective multicenter study. J Urol 177(4):1419–1422CrossRefPubMed

Rajbabu K et al (2007) Photoselective vaporization of the prostate with the potassium-titanyl-phosphate laser in men with prostates of >100 mL. BJU Int 100(3):593–598 (Discussion 598)CrossRefPubMed

Naspro R et al (2006) Holmium laser enucleation of the prostate versus open prostatectomy for prostates >70 g: 24-month follow-up. Eur Urol 50(3):563–568CrossRefPubMed

Kuntz RM, Lehrich K, Ahyai SA (2008) Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. Eur Urol 53(1):160–166CrossRefPubMed

Sun J et al (2018) Green Light photoselective vaporization of the prostate: a safe and effective treatment for elderly high-risk benign prostate hyperplasia patients with gland over 80 ml. Lasers Med Sci 33(8):1693–1698CrossRefPubMed

Hueber PA et al (2015) Photoselective vaporization of the prostate for benign prostatic hyperplasia using the 180 watt system: multicenter study of the impact of prostate size on safety and outcomes. J Urol 194(2):462–469CrossRefPubMed

10.

Meskawi M et al (2017) Multicenter international experience of 532 nm-laser photo-vaporization with Greenlight XPS in men with large prostates (prostate volume > 100 cc). World J Urol 35(10):1603–1609CrossRefPubMed

11.

Stone BV et al (2016) GreenLight laser for prostates over 100 ml: what is the evidence? Curr Opin Urol 26(1):28–34CrossRefPubMed

12.

Chen CH et al (2012) High-intensity diode laser in combination with bipolar transurethral resection of the prostate: a new strategy for the treatment of large prostates (>80 ml). Lasers Surg Med 44(9):699–704CrossRefPubMed

13.

Stoffel JT et al (2017) AUA white paper on nonneurogenic chronic urinary retention: consensus definition, treatment algorithm, and outcome end points. J Urol 198(1):153–160CrossRefPubMed

14.

Woo H et al (2008) Outcome of GreenLight HPS 120-W laser therapy in specific patient populations: those in retention, on anticoagulants, and with large prostates (≥ 80ml). Eur Urol Suppl 7(4):378–383CrossRef

15.

Seitz M et al (2009) High-power diode laser at 980 nm for the treatment of benign prostatic hyperplasia: ex vivo investigations on porcine kidneys and human cadaver prostates. Lasers Med Sci 24(2):172–178CrossRefPubMed

16.

Heinrich E et al (2010) 120 W lithium triborate laser for photoselective vaporization of the prostate: comparison with 80 W potassium-titanyl-phosphate laser in an ex vivo model. J Endourol 24(1):75–79CrossRefPubMed

17.

Malek RS et al (2011) Photoselective vaporization prostatectomy: experience with a novel 180 W 532 nm lithium triborate laser and fiber delivery system in living dogs. J Urol 185(2):712–718CrossRefPubMed

18.

Chen CH et al (2010) Preliminary results of prostate vaporization in the treatment of benign prostatic hyperplasia by using a 200-W high-intensity diode laser. Urology 75(3):658–663CrossRefPubMed

19.

Chiang PH, Chen CH (2010) Prostate vaporization in the treatment of benign prostatic hyperplasia by using a 200-w high-intensity diode laser. Curr Urol Rep 11(4):249–253CrossRefPubMed

20.

Chiang PH et al (2010) GreenLight HPS laser 120-W versus diode laser 200-W vaporization of the prostate: comparative clinical experience. Lasers Surg Med 42(7):624–629CrossRefPubMed

21.

Romero-Otero J et al (2019) Factors influencing intraoperative blood loss in patients undergoing holmium laser enucleation of the prostate (HoLEP) for benign prostatic hyperplasia: a large multicenter analysis. Urology 132:177–182CrossRefPubMed

22.

Zhang ZH et al (2018) Management of greenlight laser plus transurethral resection of prostate for elderly men. Medicine (Baltimore) 97(33):e11862CrossRefPubMed

23.

Al-Ansari A et al (2010) GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up. Eur Urol 58(3):349–355CrossRefPubMed

24.

Thomas JA et al (2016) A multicenter randomized noninferiority trial comparing GreenLight-XPS laser vaporization of the prostate and transurethral resection of the prostate for the treatment of benign prostatic obstruction: two-yr outcomes of the GOLIATH Study. Eur Urol 69(1):94–102CrossRefPubMed

25.

Zhou Y et al (2016) Greenlight high-performance system (HPS) 120-W laser vaporization versus transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: a meta-analysis of the published results of randomized controlled trials. Lasers Med Sci 31(3):485–495CrossRefPubMed

26.

Bachmann A et al (2012) 180-W XPS GreenLight laser therapy for benign prostate hyperplasia: early safety, efficacy, and perioperative outcome after 201 procedures. Eur Urol 61(3):600–607CrossRefPubMed

27.

Altay B et al (2015) 180-W XPS GreenLight laser vaporization for benign prostate hyperplasia: 12-month safety and efficacy results for glands larger than 80 mL. Lasers Med Sci 30(1):317–323CrossRefPubMed

28.

Hueber PA et al (2013) 180 W vs. 120 W lithium triborate photoselective vaporization of the prostate for benign prostatic hyperplasia: a global, multicenter comparative analysis of perioperative treatment parameters. Urology 82(5):1108–1113CrossRefPubMed

29.

Emara AM, Barber NJ (2014) The continuous evolution of the Greenlight laser; the XPS generator and the MoXy laser fiber, expanding the indications for photoselective vaporization of the prostate. J Endourol 28(1):73–78CrossRefPubMed

30.

Bachmann A et al (2015) A European multicenter randomized noninferiority trial comparing 180 W GreenLight XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH study. J Urol 193(2):570–578CrossRefPubMed

Title: Combination of 180-W GreenLight XPS laser and bipolar transurethral resection of prostate for the treatment of large prostates beyond 100 ml: a novel hybrid technique
Authors: Mu-Yao Tsai
Chien-Hsu Chen
Po-Hui Chiang
Ping-Chia Chiang
Publication date: 28-07-2023
Publisher: Springer Netherlands
Keywords: Transurethral Prostate Resection
Laser
Published in: International Urology and Nephrology / Issue 11/2023
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI: https://doi.org/10.1007/s11255-023-03723-w

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background and objectives

Study design/materials and methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 11/2023

Predictive value of Prognostic Nutritional Index (PNI) for the severity of vasculogenic erectile dysfunction

The predictive value of temporal muscle thickness measured by ultrasonography for detecting moderate to severe malnutrition in chronic hemodialysis patients

Hepatitis C and hepatitis B virus infection in hemodialysis patients after nationwide direct antiviral agents therapy—experience of 10 Romanian HD centers

The clinical value of monoclonal protein in ANCA-associated vasculitis with renal involvement

Balanced crystalloid solutions versus normal saline in intensive care units: a systematic review and meta-analysis

AI-predicted mpMRI image features for the prediction of clinically significant prostate cancer

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials